Recent

% | $
Quotes you view appear here for quick access.

BioTime, Inc. Message Board

  • btimnextmicrosoft btimnextmicrosoft Apr 11, 2014 8:45 PM Flag

    Biotimes next subsidiary acquisition?

    Mr. Schlachet our new BTX board of directors also serves as Chairman of the Board of our subsidiary Cell Cure Neurosciences, Ltd......and also director of BioCancell :

    About BioCancell
    BioCancell is a biopharmaceutical company that specializes in the development of Targeted Cancer Therapies for the treatment of numerous types of cancer. The Company's technology offers a safe and long-term treatment of cancer, with no adverse effects.
    BioCancell was co-founded in 2004 by Professor Avraham Hochberg, Professor of Molecular Biology at the Hebrew University of Jerusalem, based on technology developed by him over the past 25 years. The drug candidates developed by the Company are targeted and their goal is to selectively destroy the cancer cells without affecting healthy cells (‘Targeted Cancer Therapy'). The approach is based on the identification of target genes, such as H19, that are expressed only in cancerous tumors, and not in healthy cells, and on the use of those genes' regulatory sequences for the activation of a toxin inside the cancerous cells only, thus destroying them without harming healthy cells. BioCancell's leading drug candidate, BC-819, has completed a Phase IIb clinical trial for the treatment of bladder cancer, as well as additional clinical trials for other cancer indications.

    BioCancell’s Phase I clinical trial for BC-821, scheduled to commence in 2015, is a continuation of the success of pre-clinical studies that have examined the use of BC-821 as a treatment for several cancer indications

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Dr. West is a genius.....Mr. Schlachet is also a director of Mazor Robotics Renaissance...Geron+BTX+Mazor=WINNER.

      Next-generation System for Spine Surgery
      Mazor Robotics Renaissance™ Guidance System is transforming spine surgery from freehand operations to highly-accurate, state-of-the-art procedures that may reduce fluoroscopy. It is the only mechanical guidance system for spine surgery with FDA clearance and CE marking.
      Renaissance has been used in thousands of spine procedures worldwide ranging from minimally-invasive surgery to scoliosis and other complex spinal deformity cases.

 
BTX
2.61+0.11(+4.40%)Jun 30 4:00 PMEDT